PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLOPYRIDINE DERIVATIVE AS NADPH OXIDASE INHIBITOR

Title:

PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLOPYRIDINE DERIVATIVE AS NADPH OXIDASE INHIBITOR

Document Type and Number:

Japanese Patent JP2015078222

Kind Code:

A

Abstract:

PROBLEM TO BE SOLVED: To provide a pharmaceutical formulation comprising a novel compound useful for therapy and/or prevention of diseases or conditions related to nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase).SOLUTION: A pharmaceutical formulation comprises a pyrazolopyridine derivative represented by the formula (I). (Gis H or heteroaryl; Gis H, alkyl, alkenyl, alkylaryl, heteroaryl or the like; Gis H, amino, aminoalkyl, aminocarbonyl or the like; Gis -NR-C(O)-Ror -(CHR)-(CH)-R; and Gis H.)

Inventors:

PATRICK PAGE
MIKE ORCHARD
BENOIT LALEU
FRANCESCA GAGGINI

Application Number:

JP2014254651A

Publication Date:

April 23, 2015

Filing Date:

December 17, 2014

Export Citation:

Click for automatic bibliography generation Help

Assignee:

GENKYOTEX SA

International Classes:

A61K31/5377; A61K31/437; A61K31/444; A61K31/496; A61K31/5025; A61P1/02; A61P1/04; A61P1/16; A61P1/18; A61P7/02; A61P9/00; A61P9/04; A61P9/10; A61P9/12; A61P11/00; A61P11/02; A61P11/06; A61P13/08; A61P13/10; A61P13/12; A61P15/00; A61P15/10; A61P17/00; A61P19/00; A61P19/10; A61P21/00; A61P25/00; A61P27/02; A61P29/00; A61P31/16; A61P35/00; A61P37/06; A61P37/08; A61P43/00

Domestic Patent References:

JP2010521522A	2010-06-24
JP5700837B2	2015-04-15
JP2010521522A	2010-06-24

Other References:

JPN6011013330; Ｂｉｏｏｒｇ　Ｍｅｄ　Ｃｈｅｍ　Ｌｅｔｔ，　ｖｏｌ．１０，　ｐ．２５８５-２５８８　（２０００）Ｖｏｌ．１０, 2007, ｐ．３５８２-３５９０
JPN7014000464; ＲＥＧＩＳＴＲＹ（ＳＴＮ）［ｏｎｌｉｎｅ］
JPN6011013330; Ｂｉｏｏｒｇ　Ｍｅｄ　Ｃｈｅｍ　Ｌｅｔｔ，　ｖｏｌ．１０，　ｐ．２５８５-２５８８　（２０００）Ｖｏｌ．１０, 2007, ｐ．３５８２-３５９０
JPN7014000464; ＲＥＧＩＳＴＲＹ（ＳＴＮ）［ｏｎｌｉｎｅ］

Attorney, Agent or Firm:

Masayoshi Suda

Previous Patent: NOVEL COMPOSITION AND ADJUVANT

Next Patent: MECHANISM-BASED TARGETED PANCREATIC β CELL IMAGING AND THERAPY